Heart Rate Variability (HRV) and Sympathetic Nerve Activity

  • Ken Kiyono
  • Junichiro Hayano
  • Eiichi Watanabe
  • Yoshiharu Yamamoto
Chapter
First Online:

Abstract

The available epidemiological and clinical data implicate increased sympathetic nervous system activity in increased cardiovascular morbidity and mortality and show that it has strong predictive power for mortality and cardiovascular events. Analysis of heart rate variability (HRV) has been widely used as a noninvasive assessment tool for autonomic nervous system function, and results show that reduced and/or abnormal HRV is associated with an increased risk of mortality in cardiac patients such as patients after acute myocardial infarction and patients with congestive heart failure. However, most indices derived from HRV primarily reflect vagal function. In contrast, few indices have been suggested as markers of sympathetic nervous system activity. This chapter reviews characteristics of HRV that have been proposed as potential markers of cardiac sympathetic activity, such as (in the frequency domain) low-frequency (LF) power, short-term scaling exponent, and non-Gaussianity index. While there is no widely accepted and well-tested HRV-based index of cardiac sympathetic activity, we discuss the key issues for the assessment of cardiac sympathetic activity based on HRV analysis.

Keywords

Heart rate variability Autonomic nervous system Sympathetic nervous system Nonlinear index 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Esler M, Kaye D. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol. 2000;35:S1–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Malpas SC. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev. 2010;90:513–57. doi: 10.1152/physrev.00007.2009.CrossRefPubMedGoogle Scholar
  3. 3.
    Perret-Guillaume C, Joly L, Benetos A. Heart rate as a risk factor for cardiovascular disease. Prog Cardiovasc Dis. 2009;52:6–10. doi: 10.1016/j.pcad.2009.05.003.CrossRefPubMedGoogle Scholar
  4. 4.
    Palatini P, Benetos A, Grassi G, Julius S, Kjeldsen SE, Mancia G, et al. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens. 2006;24:603–10.CrossRefPubMedGoogle Scholar
  5. 5.
    Palatini P. Elevated heart rate in cardiovascular diseases: a target for treatment? Prog Cardiovasc Dis. 2009;52:46–60. doi: 10.1016/j.pcad.2009.05.005.CrossRefPubMedGoogle Scholar
  6. 6.
    Lang CC, Gupta S, Kalra P, Keavney B, Menown I, Morley C, et al. Elevated heart rate and cardiovascular outcomes in patients with coronary artery disease: clinical evidence and pathophysiological mechanisms. Atherosclerosis. 2010;212:1–8. doi: 10.1016/j.atherosclerosis.2010.01.029.CrossRefPubMedGoogle Scholar
  7. 7.
    Custodis F, Reil JC, Laufs U, Bohm M. Heart rate: a global target for cardiovascular disease and therapy along the cardiovascular disease continuum. J Cardiol. 2013;62:183–7. doi: 10.1016/j.jjcc.2013.02.018.CrossRefPubMedGoogle Scholar
  8. 8.
    Goldberg RJ, Larson M, Levy D. Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham Study. Arch Intern Med. 1996;156:505–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Kannel WB. Office assessment of coronary candidates and risk factor insights from the Framingham study. J Hypertens Suppl. 1991;9:S13–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Hozawa A, Ohkubo T, Kikuya M, Ugajin T, Yamaguchi J, Asayama K, et al. Prognostic value of home heart rate for cardiovascular mortality in the general population: the Ohasama study. Am J Hypertens. 2004;17:1005–10.PubMedGoogle Scholar
  11. 11.
    Bohm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet. 2010;376:886–94. doi: 10.1016/S0140-6736(10)61259-7.CrossRefPubMedGoogle Scholar
  12. 12.
    Sundlof G, Wallin BG. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J Physiol. 1978;274:621–37.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Ng AV, Callister R, Johnson DG, Seals DR. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension. 1993;21:498–503.CrossRefPubMedGoogle Scholar
  14. 14.
    Ziegler MG, Lake CR, Kopin IJ. Plasma noradrenaline increases with age. Nature. 1976;261:333–5.CrossRefPubMedGoogle Scholar
  15. 15.
    Barnes RF, Raskind M, Gumbrecht G, Halter JB. The effects of age on the plasma catecholamine response to mental stress in man. J Clin Endocrinol Metab. 1982;54:64–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Seals DR, Esler MD. Human ageing and the sympathoadrenal system. J Physiol. 2000;528(Pt 3):407–17.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Esler MD, Thompson JM, Kaye DM, Turner AG, Jennings GL, Cox HS, et al. Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors. Circulation. 1995;91:351–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Kaye D, Esler M. Sympathetic neuronal regulation of the heart in aging and heart failure. Cardiovasc Res. 2005;66:256–64.CrossRefPubMedGoogle Scholar
  19. 19.
    Furberg CD, Psaty BM, Meyer JV. Nifedipine dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326–31.Google Scholar
  20. 20.
    Frohlich ED, McLoughlin MJ, Losem CJ, Ketelhut R, Messerli FH. Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension. Am J Cardiol. 1991;68:1346–50.CrossRefPubMedGoogle Scholar
  21. 21.
    Thattassery E, Gheorghiade M. Beta blocker therapy after acute myocardial infarction in patients with heart failure and systolic dysfunction. Heart Fail Rev. 2004;9:107–13.CrossRefPubMedGoogle Scholar
  22. 22.
    Manurung D, Trisnohadi HB. Beta blockers for congestive heart failure. Acta Med Indones. 2007;39(1):44–8.PubMedGoogle Scholar
  23. 23.
    Kezerashvili A, Marzo K, De Leon J. Beta blocker use after acute myocardial infarction in the patient with normal systolic function: when is it “ok” to discontinue? Curr Cardiol Rev. 2012;8:77–84.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–23.CrossRefPubMedGoogle Scholar
  25. 25.
    Cohn JN. Plasma norepinephrine and mortality. Clin Cardiol. 1995;18:I9–12.CrossRefPubMedGoogle Scholar
  26. 26.
    de Lucia C, Femminella GD, Gambino G, Pagano G, Allocca E, Rengo C, et al. Adrenal adrenoceptors in heart failure. Front Physiol. 2014;5:246. doi: 10.3389/fphys.2014.00246.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Gheorghiade M, Colucci WS, Swedberg K. β-blockers in chronic heart failure. Circulation. 2003;107:1570–5. doi: 10.1161/01.CIR.0000065187.80707.18.CrossRefPubMedGoogle Scholar
  28. 28.
    Kubon C, Mistry NB, Grundvold I, Halvorsen S, Kjeldsen SE, Westheim AS. The role of beta-blockers in the treatment of chronic heart failure. Trends Pharmacol Sci. 2011;32:206–12. doi: 10.1016/j.tips.2011.01.006.CrossRefPubMedGoogle Scholar
  29. 29.
    Gilbert EM, Abraham WT, Olsen S, Hattler B, White M, Mealy P, et al. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation. 1996;94:2817–25.CrossRefPubMedGoogle Scholar
  30. 30.
    Schwartz PJ, Billman GE, Stone HL. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. Circulation. 1984;69:790–800.CrossRefPubMedGoogle Scholar
  31. 31.
    Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull Jr SS, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res. 1991;68:1471–81.CrossRefPubMedGoogle Scholar
  32. 32.
    Zhou S, Jung BC, Tan AY, Trang VQ, Gholmieh G, Han SW, et al. Spontaneous stellate ganglion nerve activity and ventricular arrhythmia in a canine model of sudden death. Heart Rhythm. 2008;5:131–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Malliani A, Schwartz PJ, Zanchetti A. A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol. 1969;217:703–9.PubMedGoogle Scholar
  34. 34.
    Schwartz PJ, Foreman RD, Stone HL, Brown AM. Effect of dorsal root section on the arrhythmias associated with coronary occlusion. Am J Physiol. 1976;231:923–8.PubMedGoogle Scholar
  35. 35.
    Camm J, Malik M, Bigger Jr JT, Breithardt G, Cerutti S, Cohen RJ, et al. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;93:1043–65.CrossRefGoogle Scholar
  36. 36.
    Kleiger RE, Miller JP, Bigger Jr JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256–62.CrossRefPubMedGoogle Scholar
  37. 37.
    La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation. 2003;107:565–70.CrossRefPubMedGoogle Scholar
  38. 38.
    Buccelletti E, Gilardi E, Scaini E, Galiuto L, Persiani R, Biondi A, et al. Heart rate variability and myocardial infarction: systematic literature review and metanalysis. Eur Rev Med Pharmacol Sci. 2009;13:299–307.PubMedGoogle Scholar
  39. 39.
    Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991;84:482–92.CrossRefPubMedGoogle Scholar
  40. 40.
    Furlan R, Guzzetti S, Crivellaro W, Dassi S, Tinelli M, Baselli G, et al. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation. 1990;81:537–47.CrossRefPubMedGoogle Scholar
  41. 41.
    Hopf HB, Skyschally A, Heusch G, Peters J. Low-frequency spectral power of heart rate variability is not a specific marker of cardiac sympathetic modulation. Anesthesiology. 1995;82:609–19.CrossRefPubMedGoogle Scholar
  42. 42.
    Taylor JA, Carr DL, Myers CW, Eckberg DL. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation. 1998;98:547–55.CrossRefPubMedGoogle Scholar
  43. 43.
    Goldstein DS, Bentho O, Park MY, Sharabi Y. Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes. Exp Physiol. 2011;96:1255–61. doi: 10.1113/expphysiol.2010.056259.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Reyes del Paso GA, Langewitz W, Mulder LJ, van Roon A, Duschek S. The utility of low frequency heart rate variability as an index of sympathetic cardiac tone: a review with emphasis on a reanalysis of previous studies. Psychophysiology. 2013;50:477–87. doi: 10.1111/psyp.12027.CrossRefPubMedGoogle Scholar
  45. 45.
    Bigger Jr JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 1992;85:164–71.CrossRefPubMedGoogle Scholar
  46. 46.
    Bigger Jr JT, Fleiss JL, Rolnitzky LM, Steinman RC. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol. 1993;21:729–36. Erratum in: J Am Coll Cardiol 1993;21:1537.CrossRefPubMedGoogle Scholar
  47. 47.
    Huikuri HV, Makikallio TH, Peng CK, Goldberger AL, Hintze U, Moller M. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation. 2000;101:47–53.CrossRefPubMedGoogle Scholar
  48. 48.
    Stein PK, Domitrovich PP, Huikuri HV, Kleiger RE, Cast Investigators. Traditional and nonlinear heart rate variability are each independently associated with mortality after myocardial infarction. J Cardiovasc Electrophysiol. 2005;16:13–20.CrossRefPubMedGoogle Scholar
  49. 49.
    Voss A, Schulz S, Schroeder R, Baumert M, Caminal P. Methods derived from nonlinear dynamics for analysing heart rate variability. Philos Trans A Math Phys Eng Sci. 2009;367:277–96.CrossRefPubMedGoogle Scholar
  50. 50.
    Sassi R, Cerutti S, Lombardi F, Malik M, Huikuri HV, Peng C-K, et al. Advances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm Society. Europace. 2015;17:1341–53. doi: 10.1093/europace/euv015.CrossRefPubMedGoogle Scholar
  51. 51.
    Peng CK, Havlin S, Stanley HE, Goldberger AL. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos. 1995;5:82–7.CrossRefPubMedGoogle Scholar
  52. 52.
    Makikallio TH, Huikuri HV, Makikallio A, Sourander LB, Mitrani RD, Castellanos A, et al. Prediction of sudden cardiac death by fractal analysis of heart rate variability in elderly subjects. J Am Coll Cardiol. 2001;37:1395–402.CrossRefPubMedGoogle Scholar
  53. 53.
    Tapanainen JM, Thomsen PE, Kober L, Torp-Pedersen C, Makikallio TH, Still AM, et al. Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. Am J Cardiol. 2002;90:347–52.CrossRefPubMedGoogle Scholar
  54. 54.
    Kiyono K, Hayano J, Watanabe E, Struzik ZR, Yamamoto Y. Non-Gaussian heart rate as an independent predictor of mortality in patients with chronic heart failure. Heart Rhythm. 2008;5:261–8. doi: 10.1016/j.hrthm.2007.10.030.CrossRefPubMedGoogle Scholar
  55. 55.
    Hayano J, Kiyono K, Struzik ZR, Yamamoto Y, Watanabe E, Stein PK, et al. Increased non-gaussianity of heart rate variability predicts cardiac mortality after an acute myocardial infarction. Front Physiol. 2011;2:65. doi: 10.3389/fphys.2011.00065.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Kiyono K, Hayano J, Kwak S, Watanabe E, Yamamoto Y. Non-gaussianity of low frequency heart rate variability and sympathetic activation: lack of increases in multiple system atrophy and Parkinson disease. Front Physiol. 2012;3:34. doi: 10.3389/fphys.2012.00034.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Willson K, Francis DP, Wensel R, Coats AJ, Parker KH. Relationship between detrended fluctuation analysis and spectral analysis of heart-rate variability. Physiol Meas. 2002;23:385–401.CrossRefPubMedGoogle Scholar
  58. 58.
    Willson K, Francis DP. A direct analytical demonstration of the essential equivalence of detrended fluctuation analysis and spectral analysis of RR interval variability. Physiol Meas. 2003;24:N1–7.CrossRefPubMedGoogle Scholar
  59. 59.
    Cacioppo JT, Berntson GG, Binkley PF, Quigley KS, Uchino BN, Fieldstone A. Autonomic cardiac control. II. Noninvasive indices and basal response as revealed by autonomic blockades. Psychophysiology. 1994;31:586–98.CrossRefPubMedGoogle Scholar
  60. 60.
    Taylor JA, Myers CW, Halliwill JR, Seidel H, Eckberg DL. Sympathetic restraint of respiratory sinus arrhythmia: implications for vagal-cardiac tone assessment in humans. Am J Physiol Heart Circ Physiol. 2001;280:H2804–14.PubMedGoogle Scholar
  61. 61.
    Grossman P, Taylor EW. Toward understanding respiratory sinus arrhythmia: relations to cardiac vagal tone, evolution and biobehavioral functions. Biol Psychol. 2007;74:263–85.CrossRefPubMedGoogle Scholar
  62. 62.
    Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam D, Gordon D, et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 1985;248:H151–3.PubMedGoogle Scholar
  63. 63.
    Moak JP, Goldstein DS, Eldadah BA, Saleem A, Holmes C, Pechnik S, et al. Supine low-frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation. Heart Rhythm. 2007;4:1523–9.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Rahman F, Pechnik S, Gross D, Sewell L, Goldstein DS. Low frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation. Clin Auton Res. 2011;21:133–41. doi: 10.1007/s10286-010-0098-y.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Hamilton JD. Time series analysis. Princeton: Princeton University Press; 1994.Google Scholar
  66. 66.
    Huikuri HV, Makikallio TH, Airaksinen KE, Seppanen T, Puukka P, Raiha IJ, et al. Power-law relationship of heart rate variability as a predictor of mortality in the elderly. Circulation. 1998;97:2031–6.CrossRefPubMedGoogle Scholar
  67. 67.
    Ivanov PC, Amaral LA, Goldberger AL, Havlin S, Rosenblum MG, Struzik ZR, et al. Multifractality in human heartbeat dynamics. Nature. 1999;399:461–5.CrossRefPubMedGoogle Scholar
  68. 68.
    Tulppo MP, Mäkikallio TH, Takala TE, Seppänen T, Huikuri HV. Quantitative beat-to-beat analysis of heart rate dynamics during exercise. Am J Physiol. 1996;271:H244–52.PubMedGoogle Scholar
  69. 69.
    Richman JS, Moorman JR. Physiological time-series analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol. 2000;278:H2039–49.PubMedGoogle Scholar
  70. 70.
    Porta A, Guzzetti S, Montano N, Furlan R, Pagani M, Malliani A, et al. Entropy, entropy rate, and pattern classification as tools to typify complexity in short heart period variability series. IEEE Trans Biomed Eng. 2001;48:1282–91.CrossRefPubMedGoogle Scholar
  71. 71.
    Costa M, Goldberger AL, Peng C-K. Multiscale entropy analysis of physiologic time series. Phys Rev Lett. 2002;89:062102.CrossRefGoogle Scholar
  72. 72.
    Yang AC, Hseu SS, Yien HW, Goldberger AL, Peng CK. Linguistic analysis of the human heartbeat using frequency and rank order statistics. Phys Rev Lett. 2003;90:108103.CrossRefPubMedGoogle Scholar
  73. 73.
    Kiyono K, Struzik ZR, Aoyagi N, Sakata S, Hayano J, Yamamoto Y. Critical scale invariance in a healthy human heart rate. Phys Rev Lett. 2004;93:178103.CrossRefPubMedGoogle Scholar
  74. 74.
    Jokinen V, Tapanainen JM, Seppänen T, Huikuri HV. Temporal changes and prognostic significance of measures of heart rate dynamics after acute myocardial infarction in the beta-blocking era. Am J Cardiol. 2003;92:907–12.CrossRefPubMedGoogle Scholar
  75. 75.
    Perkiömäki JS, Bloch Thomsen PE, Kiviniemi AM, Messier MD, Huikuri HV, CARISMA Study Investigators. Risk factors of self-terminating and perpetuating ventricular tachyarrhythmias in post-infarction patients with moderately depressed left ventricular function, a CARISMA sub-analysis. Europace. 2011;13:1604–11. doi: 10.1093/europace/eur166.CrossRefPubMedGoogle Scholar
  76. 76.
    Gang UJ, Jøns C, Jørgensen RM, Abildstrøm SZ, Messier MD, Haarbo J, et al. Risk markers of late high-degree atrioventricular block in patients with left ventricular dysfunction after an acute myocardial infarction: a CARISMA substudy. Europace. 2011;13:1471–7. doi: 10.1093/europace/eur165.CrossRefPubMedGoogle Scholar
  77. 77.
    Perkiömäki JS, Jokinen V, Tapanainen J, Airaksinen KE, Huikuri HV. Autonomic markers as predictors of nonfatal acute coronary events after myocardial infarction. Ann Noninvasive Electrocardiol. 2008;13:120–9. doi: 10.1111/j.1542-474X.2008.00211.x.
  78. 78.
    Kiyono K, Struzik ZR, Aoyagi N, Yamamoto Y. Multiscale probability density function analysis: non-Gaussian and scale-invariant fluctuations of healthy human heart rate. IEEE Trans Biomed Eng. 2006;53(1):95–102.Google Scholar
  79. 79.
    Kiyono K, Struzik ZR, Yamamoto Y. Estimator of a non-Gaussian parameter in multiplicative log-normal models. Phys Rev E. 2007;76:041113.CrossRefGoogle Scholar
  80. 80.
    Frish U. Turbulence. Cambridge: Cambridge University Press; 1995.Google Scholar
  81. 81.
    Altimiras J. Understanding autonomic sympathovagal balance from short-term heart rate variations. Are we analyzing noise? Comp Biochem Physiol A Mol Integr Physiol. 1999;124:447–60.CrossRefPubMedGoogle Scholar
  82. 82.
    Sone M, Yoshida M, Hashizume Y, Hishikawa N, Sobue G. Alpha-synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy. Acta Neuropathol. 2005;110:19–26.CrossRefPubMedGoogle Scholar
  83. 83.
    Braune S, Reinhardt M, Bathmann J, Krause T, Lehmann M, Lücking CH. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson’s disease with autonomic failure. Acta Neurol Scand. 1998;97:307–14.CrossRefPubMedGoogle Scholar
  84. 84.
    Braune S, Reinhardt M, Schnitzer R, Riedel A, Lücking CH. Cardiac uptake of [123I]MIBG separates Parkinson’s disease from multiple system atrophy. Neurology. 1999;53:1020–5.CrossRefPubMedGoogle Scholar
  85. 85.
    Vikman S, Mäkikallio TH, Yli-Mäyry S, Pikkujämsä S, Koivisto AM, Reinikainen P, et al. Altered complexity and correlation properties of R-R interval dynamics before the spontaneous onset of paroxysmal atrial fibrillation. Circulation. 1999;100:2079–84.CrossRefPubMedGoogle Scholar
  86. 86.
    Porta A, Gnecchi-Ruscone T, Tobaldini E, Guzzetti S, Furlan R, Montano N. Progressive decrease of heart period variability entropy-based complexity during graded head-up tilt. J Appl Physiol. 2007;103:1143–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Japan 2017

Authors and Affiliations

  • Ken Kiyono
    • 1
  • Junichiro Hayano
    • 2
  • Eiichi Watanabe
    • 3
  • Yoshiharu Yamamoto
    • 4
  1. 1.Division of Bioengineering, Graduate School of Engineering ScienceOsaka UniversityToyonakaJapan
  2. 2.Department of Medical Education, Graduate School of Medical SciencesNagoya City UniversityNagoyaJapan
  3. 3.Division of Cardiology, Department of Internal Medicine, School of MedicineFujita Health UniversityToyoakeJapan
  4. 4.Educational Physiology Laboratory, Graduate School of EducationUniversity of TokyoTokyoJapan

Personalised recommendations